About 285,000 results
Natural-gas producer BKV and drug-developer BioAge queue up …
BioAge, BKV shares end their first trading day flat after earlier gains
BioAge posts double-digit percentage jump after IPO; natural-gas ...
BKV Corporation Announces Closing of Initial Public Offering
Weight-loss drug developer BioAge Labs aims to raise $198M …
BioAge, BKV shares end their first trading day flat after earlier gains
BKV Corporation Announces Pricing of Initial Public Offering
BKV Corporation (BKV) Stock Price, News, Quote & History
Natgas producer BKV valued at $1.56 billion in NYSE debut
IPOs debuting from BKV and BioAge - MarketWatch
- Some results have been removed